Healthcare -
Biotechnology - NASDAQ - US
$ 0.6772
0.296 %
$ 53 M
Market Cap
4.23
P/E
CTMX - STOCK-BASED COMPENSATION
Stock-based Compensation CTMX - CytomX Therapeutics, Inc.
8.56 M
LAST VALUE
-19.38%
2 YEAR CAGR
-12.70%
5 YEAR CAGR
37.95%
10 YEAR CAGR